✦ LIBER ✦

Reboxetine may be beneficial for depression in patients with Parkinson's disease

Book ID: 120863642
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2002
Weight: 133 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200213410-00027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safinamide may be beneficial in Parkinso

Safinamide may be beneficial in Parkinson's disease

📂 Article 📅 2003 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

P01.131 Treatment of depression in Parki

P01.131 Treatment of depression in Parkinson's disease with reboxetine

✍ M.R. Lemke 📂 Article 📅 2000 🏛 Elsevier Science 🌐 French ⚖ 126 KB

Depression in patients with Parkinson's

Depression in patients with Parkinson's disease

✍ Jeffrey L. Cummings; Donna L. Masterman 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Parkinson's disease (PD) is a disabling neurodegenerative condition commonly complicated by the existence of comorbid depression. The prevalence rates of depression in this patient group have been reported to be as high as 40%. Currently, depression in PD is undertreated; there have been few control

Response to 4-month treatment with rebox

Response to 4-month treatment with reboxetine in Parkinson's disease patients with a major depressive episode

✍ Luis Pintor; Eva Baillès; Francesc Valldeoriola; Eduard Tolosa; María J. Martí; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Use of antidepressants for depression in

Use of antidepressants for depression in patients with Parkinson's disease

✍ Pae, Chi-Un 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 165 KB

Pentostatin may be beneficial in patient

Pentostatin may be beneficial in patients with GVHD

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB